Predisposition of Wolfram syndrome heterozygotes to psychiatric illness

RG Swift, MH Polymeropoulos, R Torres, M Swift - Molecular psychiatry, 1998 - nature.com
RG Swift, MH Polymeropoulos, R Torres, M Swift
Molecular psychiatry, 1998nature.com
Identification of specific genes that predispose to psychiatric illness will lead to more precise
psychiatric diagnosis and more effective treatment. Heterozygous carriers of genes for many
autosomal recessive syndromes may be 1% or more of the general population. Thus, if
mutations at a specific locus produce psychiatric manifestations in homozygous affected
individuals, it is important to determine whether mutations at such a locus also predispose
heterozygous carriers to psychiatric disorders. The hypothesis that heterozygous carriers of …
Abstract
Identification of specific genes that predispose to psychiatric illness will lead to more precise psychiatric diagnosis and more effective treatment. Heterozygous carriers of genes for many autosomal recessive syndromes may be 1% or more of the general population. Thus, if mutations at a specific locus produce psychiatric manifestations in homozygous affected individuals, it is important to determine whether mutations at such a locus also predispose heterozygous carriers to psychiatric disorders. The hypothesis that heterozygous carriers of the gene for the Wolfram syndrome (WS) are predisposed to psychiatric illness was supported previously by the finding of an excess of psychiatric hospitalizations and suicides in WS blood relatives compared to spouse controls. 1 This hypothesis has now been tested further by comparing the number of psychiatrically hospitalized blood relatives with the specific marker haplotype associated with the Wolfram syndrome gene in their families to the number expected under the null hypothesis, calculated from Mendelian inheritance principles and the estimated haplotype frequency. 2 The proportion of psychiatrically hospitalized relatives who were WS carriers (10/11) was much higher than expected (3.1/11), leading to the provisional estimate that WS gene carriers are 26-fold more likely to require psychiatric hospitalization than non-carriers.
nature.com